BioRestorative Therapies Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq
26 oct. 2021 16h05 HE
|
BioRestorative Therapies, Inc
MELVILLE, NY, Oct. 26, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BRTX” or the “Company”) (OTC: BRTX), a life sciences company focused on adult stem cell-based therapies, today...
BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program
23 sept. 2021 09h00 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Sept. 23, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Awarded One of Top 10 Spine Device Companies by MedTech Outlook
19 août 2021 06h00 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,...
BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
09 août 2021 11h58 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
BioRestorative Therapies to Present at the Emerging Growth Conference on June 9, 2021
07 juin 2021 06h00 HE
|
BioRestorative Therapies, Inc
BioRestorative Therapies invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the online Emerging Growth Conference. ...
BioStem Technologies, Announces Filing of 2020 Quarterly Reports
24 déc. 2020 14h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, Fl, Dec. 24, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
CORRECTION—Juva Life Commences Trading Under CSE Ticker Symbol JUVA
17 nov. 2020 11h55 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Previous release had an incorrect area code on the contact phone number (888 should have been 833). This has been corrected. Juva...
Juva Life Commences Trading Under CSE Ticker Symbol JUVA
17 nov. 2020 08h00 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTC: JUVAF) (“Juva Life,” “Juva” or the “Company”), a premier California based multi-faceted life sciences...
BioStem Technologies, Inc. Announces Update Regarding Timeline to Become Current Reporting with OTC Markets During Q4 2020
22 juil. 2020 17h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 22, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...
BioStem Life Sciences Receives Accreditation by The American Association of Tissue Banks® (AATB®)
15 juil. 2020 09h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 15, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...